首頁 > 市場調查報告書 > 醫療設備

體外診斷孤兒藥

市場調查報告書

商品編碼

2148313

罕見疾病診斷市場：依檢測類型、技術、疾病類型、檢體類型、最終用戶和地區分類

Rare Disease Diagnostics Market, By Test Type, By Technology, By Disease Type, By Sample Type, By End User, By Geography

出版日期: 2026年09月22日 | 出版商:

Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，罕見疾病診斷市場規模將達到 28.6 億美元，到 2033 年將達到 71.3 億美元。預計 2026 年至 2033 年的複合年成長率將達到 13.9%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	28.6億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	13.90%	2033年市場規模預測：	71.3億美元

罕見疾病（也稱為孤兒病）僅影響一小部分人口，在美國通常影響不到20萬人，在歐洲則不到兩千分之一。全球整體，超過7,000種罕見疾病影響著3億多人，其中絕大多數是遺傳性的。該市場涵蓋用於識別、確診和監測這些複雜多樣疾病的技術和方法，包括基因測序、生物標記分析、酶活性檢測、影像技術和次世代定序平台。

雖然疾病意識的提高、基因組學的進步、製藥和生物技術公司投資的增加以及支持性的管理體制都在促進市場成長，但罕見疾病的複雜性和漫長的診斷過程仍然凸顯了對更快、更準確的診斷解決方案的需求。

市場動態

全球罕見疾病診斷市場的發展主要受人們對罕見遺傳疾病的認知不斷提高以及對早期精準診斷需求日益成長的推動。次世代定序（NGS）、全基因測序、生物標記分析和人工智慧輔助診斷技術的進步，在提升分子層面疾病檢測能力和縮短診斷時間方面發揮著至關重要的作用。主要市場的政府獎勵和有利的監管環境，進一步促進了罕見疾病診斷領域的投資和創新。

然而，該市場面臨許多限制因素，包括高昂的檢測成本、缺乏專業的診斷技術、醫療基礎設施不足以及患者群體分佈不均，尤其是在開發中國家。另一方面，新生兒篩檢計畫、精準醫療計畫、數位健康平台和病患登記系統的擴展，為早期診斷和提高專業檢測的可及性創造了機會；同時，新興市場對罕見疾病診斷基礎設施建設的投入增加，也為未來的市場成長提供了支撐。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球罕見疾病診斷市場主要公司的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份《全球罕見疾病診斷市場》報告的目標受群眾外包括產業內的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球罕見疾病診斷市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第10章競爭格局

Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
Quest Diagnostics Incorporated
Laboratory Corporation of America Holdings
Illumina, Inc.
Eurofins Scientific SE
QIAGEN NV
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
CENTOGENE NV

第11章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第12章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI10130

Rare Disease Diagnostics Market is estimated to be valued at USD 2.86 Bn in 2026 and is expected to reach USD 7.13 Bn by 2033, growing at a compound annual growth rate (CAGR) of 13.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 2.86 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	13.90%	2033 Value Projection:	USD 7.13 Bn

Rare diseases, also known as orphan diseases, affect a small percentage of the population, usually less than 200,000 people in the U.S. or fewer than 1 in 2,000 people in Europe. In total, more than 7,000 rare diseases affect more than 300 million people worldwide, most of which are of genetic origin. The market covers the technologies and methods used to identify, confirm and monitor these complicated and heterogeneous conditions The market includes genome sequencing, biomarker analysis, enzyme assays, imaging technologies, and next-generation sequencing platforms.

Increasing disease awareness, advances in genomic technologies, rising investment by pharmaceutical and biotechnology companies, and supportive regulatory structures are contributing to market growth, while the complexity of rare diseases and extended diagnostic journeys continue to highlight the need for faster and more accurate diagnostic solutions

Market Dynamics

The global rare disease diagnostics market is driven by the increasing awareness about rare genetic conditions and the increasing demand for early and accurate diagnosis. Advances in next-generation sequencing (NGS), whole genome sequencing, biomarker analysis and AI-enabled diagnostics are playing a vital role in improving the detection of diseases at the molecular scale and reducing the diagnostic timelines. The government incentives and favorable regulatory landscape in the key markets are further supporting the investments and innovations in the area of rare disease diagnostics

However, a number of constraints are present in the market, such as high costs of testing, limited availability of specialized diagnostic expertise, the lack of adequate healthcare infrastructure and the highly fragmented patient population especially in the developing economies. Meanwhile, the expansion of newborn screening programs, precision medicine initiatives, digital health platforms, and patient registries are creating opportunities to enable earlier diagnosis and wider access to specialized testing while the increasing investments in the development of rare disease diagnostic infrastructure in emerging markets are supporting the future market expansion.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global rare disease diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Quest Diagnostics Incorporated, Laboratory Corporation of America Holdings, Illumina, Inc., Eurofins Scientific SE, QIAGEN N.V., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., and CENTOGENE N.V.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global rare disease diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global rare disease diagnostics market

Market Segmentation

Test Type Insights (Revenue, USD Bn, 2021 - 2033)
- Genetic Testing
- Biochemical Testing
- Molecular Diagnostics
- Imaging Diagnostics
- Others
Technology Insights (Revenue, USD Bn, 2021 - 2033)
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Sanger Sequencing
- Microarray
- Mass Spectrometry
- Immunoassays
- Others
Disease Type Insights (Revenue, USD Bn, 2021 - 2033)
- Neurological Disorders
- Metabolic and Endocrine Disorders
- Hematological Disorders
- Immunological Disorders
- Cardiovascular Disorders
- Genetic Cancers
- Musculoskeletal Disorders
- Others
Sample Type Insights (Revenue, USD Bn, 2021 - 2033)
- Blood
- Saliva
- Buccal Swab
- Urine
- Tissue
- Cerebrospinal Fluid (CSF)
- Others
End User Insights (Revenue, USD Bn, 2021 - 2033)
- Diagnostic Laboratories
- Hospitals and Clinics
- Research and Academic Institutions
- Pharmaceutical and Biotechnology Companies
- Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd.
- Quest Diagnostics Incorporated
- Laboratory Corporation of America Holdings
- Illumina, Inc.
- Eurofins Scientific SE
- QIAGEN N.V.
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- CENTOGENE N.V.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Rare Disease Diagnostics Market, By Test Type
- Global Rare Disease Diagnostics Market, By Technology
- Global Rare Disease Diagnostics Market, By Disease Type
- Global Rare Disease Diagnostics Market, By Sample Type
- Global Rare Disease Diagnostics Market, By End User
- Global Rare Disease Diagnostics Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Test Type Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Industry Trends

4. Global Rare Disease Diagnostics Market, By Test Type, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Biochemical Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Molecular Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Imaging Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Rare Disease Diagnostics Market, By Technology, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Sanger Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Microarray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Mass Spectrometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Immunoassays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Rare Disease Diagnostics Market, By Disease Type, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Metabolic and Endocrine Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Hematological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Immunological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Cardiovascular Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Genetic Cancers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Musculoskeletal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Rare Disease Diagnostics Market, By Sample Type, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Saliva
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Buccal Swab
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Urine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Tissue
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Cerebrospinal Fluid (CSF)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Rare Disease Diagnostics Market, By End User, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Research and Academic Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

9. Global Rare Disease Diagnostics Market, By Region, 2021 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Thermo Fisher Scientific Inc.
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
F. Hoffmann-La Roche Ltd.
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
Quest Diagnostics Incorporated
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
Laboratory Corporation of America Holdings
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
Illumina, Inc.
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
Eurofins Scientific SE
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
QIAGEN N.V.
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies, Inc.
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories, Inc.
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies
CENTOGENE N.V.
- Company Highlights
- Test Type Portfolio
- Key Developments
- Financial Performance
- Strategies